These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 33183383)

  • 21. COVID-19: Is there a role for immunonutrition in obese patient?
    Di Renzo L; Gualtieri P; Pivari F; Soldati L; Attinà A; Leggeri C; Cinelli G; Tarsitano MG; Caparello G; Carrano E; Merra G; Pujia AM; Danieli R; De Lorenzo A
    J Transl Med; 2020 Nov; 18(1):415. PubMed ID: 33160363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronavirus disease-2019: A tocsin to our aging, unfit, corpulent, and immunodeficient society.
    Nieman DC
    J Sport Health Sci; 2020 Jul; 9(4):293-301. PubMed ID: 32389882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronavirus Disease 2019 (COVID-19) and Nutritional Status: The Missing Link?
    Silverio R; Gonçalves DC; Andrade MF; Seelaender M
    Adv Nutr; 2021 Jun; 12(3):682-692. PubMed ID: 32975565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
    Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
    Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review.
    Lisco G; De Tullio A; Giagulli VA; Guastamacchia E; De Pergola G; Triggiani V
    Endocrine; 2020 Dec; 70(3):441-453. PubMed ID: 32779091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
    Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M
    Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dark side of the spoon - glucose, ketones and COVID-19: a possible role for ketogenic diet?
    Paoli A; Gorini S; Caprio M
    J Transl Med; 2020 Nov; 18(1):441. PubMed ID: 33218357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Obesity and COVID-19 : Mechanisms involved in the collusion of two pandemics].
    Favre L; Pantet O; Papadimitriou Olivgeris M
    Rev Med Suisse; 2021 Mar; 17(731):558-563. PubMed ID: 33760416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When Pandemics Collide: the Interplay of Obesity and COVID-19.
    Mundi MS; Patel JJ; Mohamed Elfadil O; Patel J; Patel I; Nanda S; Hurt RT
    Curr Gastroenterol Rep; 2021 Nov; 23(12):26. PubMed ID: 34735631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current State of Evidence: Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic Framework.
    Galmés S; Serra F; Palou A
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32911778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nutritional Status and COVID-19 among Older Persons in Kerala, India.
    Sebastian IR; Venkitaraman S; Syamala S; Shajan A; Tennyson N; Devi Y
    Inquiry; 2021; 58():469580211059738. PubMed ID: 34870520
    [No Abstract]   [Full Text] [Related]  

  • 33. Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities.
    Yan T; Xiao R; Wang N; Shang R; Lin G
    Theranostics; 2021; 11(17):8234-8253. PubMed ID: 34373739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features?
    Busetto GM; Porreca A; Del Giudice F; Maggi M; D'Agostino D; Romagnoli D; Musi G; Lucarelli G; Palmer K; Colonna di Paliano A; Muto M; Hurle R; Terracciano D; de Cobelli O; Sciarra A; De Berardinis E; Ferro M
    Urol Int; 2020; 104(7-8):510-522. PubMed ID: 32516772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 mRNA vaccine protects against SARS-CoV-2 Omicron BA.1 infection in diet-induced obese mice through boosting host innate antiviral responses.
    Chen Y; Song W; Li C; Wang J; Liu F; Ye Z; Ren P; Tong Y; Li J; Ou Z; Lee AC; Cai JP; Wong BH; Chan JF; Yuen KY; Zhang AJ; Chu H
    EBioMedicine; 2023 Mar; 89():104485. PubMed ID: 36857860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity and Higher Risk for Severe Complications of Covid-19: What to do when the two pandemics meet.
    Valerio A; Nisoli E; Rossi AP; Pellegrini M; Todesco T; El Ghoch M
    J Popul Ther Clin Pharmacol; 2020 Jun; 27(S Pt 1):e31-e36. PubMed ID: 32650354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-grade inflammation, CoVID-19, and obesity: clinical aspect and molecular insights in childhood and adulthood.
    Muscogiuri G; Bettini S; Boschetti M; Barrea L; Savastano S; Colao A;
    Int J Obes (Lond); 2022 Jul; 46(7):1254-1261. PubMed ID: 35393519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology of COVID-19: Why Children Fare Better than Adults?
    Dhochak N; Singhal T; Kabra SK; Lodha R
    Indian J Pediatr; 2020 Jul; 87(7):537-546. PubMed ID: 32410003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection.
    Pal A; Gowdy KM; Oestreich KJ; Beck M; Shaikh SR
    Front Immunol; 2020; 11():1997. PubMed ID: 32983141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 and obesity: the meeting of two pandemics.
    Brandão SCS; Godoi ETAM; de Oliveira Cordeiro LH; Bezerra CS; de Oliveira Xavier Ramos J; de Arruda GFA; Lins EM
    Arch Endocrinol Metab; 2021 Nov; 65(1):3-13. PubMed ID: 33320454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.